Hemorrhagic & Ischemic Stroke Treatment Devices Market Size, Share & Trends Analysis Report By Treatment (Aneurysm & Hemorrhagic Stroke Interventions, Ischemic Stroke Interventions ), By End Use, By Region, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Treatment
  • 1.1.2. End Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising burden of hemorrhagic stroke
    • 3.2.1.2. Growing focus on minimally invasive procedures
    • 3.2.1.3. Technological advancements in neurovascular devices
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of devices and procedures
    • 3.2.2.2. Product recalls
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growing emphasis on R&D expansion
    • 3.2.3.2. Rising public awareness about hemorrhagic stroke
    • 3.2.3.3. Increasing clinical trials
    • 3.2.3.4. Increasing launches of devices for ischemic stroke treatment
    • 3.2.3.5. Expansion opportunities in emerging markets
    • 3.2.3.6. Rising stroke incidence among younger adults
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Complications associated with neurovascular treatments
    • 3.2.4.2. Limited skilled professionals
• 3.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
• 4.4. Aneurysm & Hemorrhagic Stroke Interventions
  • 4.4.1. Aneurysm & hemorrhagic stroke interventions market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. By indication
    • 4.4.2.1. By indication market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. Intracranial aneurysm
      • 4.4.2.2.1. Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. cSDH (MMA Embolization)
      • 4.4.2.3.1. cSDH (MMA Embolization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.4. AVM & AVF embolization
      • 4.4.2.4.1. AVM & AVF embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. By device
    • 4.4.3.1. By device market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Embolization coiling systems
      • 4.4.3.1.1. Embolization coiling systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Flow diversion systems
      • 4.4.3.2.1. Flow diversion systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Intrasaccular flow disruption devices
      • 4.4.2.3.1. Intrasaccular flow disruption devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.4. Liquid embolization agents
      • 4.4.3.4.1. Liquid embolization agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Ischemic Stroke Interventions (Mechanical Revascularization)
  • 4.5.1. Ischemic stroke interventions (Mechanical Revascularization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Stent retriever systems
    • 4.5.2.1. Stent retriever systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Aspiration-based thrombectomy systems
    • 4.5.3.1. Aspiration-based thrombectomy systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Cerebral Angioplasty & Vascular Remodeling
  • 4.6.1. Cerebral angioplasty & vascular remodeling market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Balloon angioplasty systems
    • 4.6.2.1. Balloon angioplasty systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. Intracranial & carotid stenting systems
    • 4.6.3.1. Intracranial & carotid stenting systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted)
    • 4.6.4.1. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Ancillary & procedural access devices
  • 4.7.1. Ancillary & procedural access devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. Guiding & distal access catheters
    • 4.7.2.1. Guiding & distal access catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.3. Microcatheters
    • 4.7.3.1. Microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.4. Access sheaths & wires
    • 4.7.4.1. Access sheaths & wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hemorrhagic & Ischemic Stroke Treatment Devices Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Specialty Neurosurgery Centers
  • 5.5.1. Specialty neurosurgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Ambulatory Surgical Centers
  • 5.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Regional Estimates & Trend Analysis by Treatment, and End Use

• 6.1. Regional Dashboard
• 6.2. Market Size and Trend Analysis, 2021 to 2033
• 6.3. North America
  • 6.3.1. North America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Competitive scenario
    • 6.3.2.3. Regulatory framework
    • 6.3.2.4. Reimbursement scenario
    • 6.3.2.5. U.S. hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Competitive scenario
    • 6.3.3.3. Regulatory framework
    • 6.3.3.4. Reimbursement scenario
    • 6.3.3.5. Canada hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Competitive scenario
    • 6.3.4.3. Regulatory framework
    • 6.3.4.4. Reimbursement scenario
    • 6.3.4.5. Mexico hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Competitive scenario
    • 6.4.2.3. Regulatory framework
    • 6.4.2.4. Reimbursement scenario
    • 6.4.2.5. UK hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Competitive scenario
    • 6.4.3.3. Regulatory framework
    • 6.4.3.4. Reimbursement scenario
    • 6.4.3.5. Germany hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Competitive scenario
    • 6.4.4.3. Regulatory framework
    • 6.4.4.4. Reimbursement scenario
    • 6.4.4.5. France hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Competitive scenario
    • 6.4.5.3. Regulatory framework
    • 6.4.5.4. Reimbursement scenario
    • 6.4.5.5. Italy hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Competitive scenario
    • 6.4.6.3. Regulatory framework
    • 6.4.6.4. Reimbursement scenario
    • 6.4.6.5. Spain hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Competitive scenario
    • 6.4.7.3. Regulatory framework
    • 6.4.7.4. Reimbursement scenario
    • 6.4.7.5. Sweden hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Competitive scenario
    • 6.4.8.3. Regulatory framework
    • 6.4.8.4. Reimbursement scenario
    • 6.4.8.5. Denmark hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.9. Norway
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Competitive scenario
    • 6.4.9.3. Regulatory framework
    • 6.4.9.4. Reimbursement scenario
    • 6.4.9.5. Norway hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. China hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Japan
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Japan hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Competitive scenario
    • 6.5.4.3. Regulatory framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. India hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Competitive scenario
    • 6.5.5.3. Regulatory framework
    • 6.5.5.4. Reimbursement scenario
    • 6.5.5.5. South Korea hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. Australia
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Competitive scenario
    • 6.5.6.3. Regulatory framework
    • 6.5.6.4. Reimbursement scenario
    • 6.5.6.5. Australia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. Thailand
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Competitive scenario
    • 6.5.7.3. Regulatory framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. Thailand hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Latin America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Brazil hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Argentina hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Middle East and Africa
  • 6.7.1. Middle East and Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. South Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. Saudi Arabia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. UAE hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. Kuwait hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Market Share Analysis, 2025
• 7.4. Company Heat Map Analysis
• 7.5. Strategy Mapping
  • 7.5.1. Expansion
  • 7.5.2. Mergers & Acquisition
  • 7.5.3. Partnerships & Collaborations
  • 7.5.4. New Treatment Launches
  • 7.5.5. Research And Development
  • 7.5.6. Company Profiles
  • 7.5.7. Medtronic
    • 7.5.7.1. Company overview
    • 7.5.7.2. Financial performance
    • 7.5.7.3. Treatment Benchmarking
    • 7.5.7.4. Strategic initiatives
  • 7.5.8. MicroVention, Inc. (Terumo Corporation)
    • 7.5.8.1. Company overview
    • 7.5.8.2. Financial performance
    • 7.5.8.3. Treatment Benchmarking
    • 7.5.8.4. Strategic initiatives
  • 7.5.9. Balt
    • 7.5.9.1. Company overview
    • 7.5.9.2. Financial performance
    • 7.5.9.3. Treatment Benchmarking
    • 7.5.9.4. Strategic initiatives
  • 7.5.10. Scientia Vascular, Inc.
    • 7.5.10.1. Company overview
    • 7.5.10.2. Financial performance
    • 7.5.10.3. Treatment Benchmarking
    • 7.5.10.4. Strategic initiatives
  • 7.5.11. MicroPort Scientific Corporation
    • 7.5.11.1. Company overview
    • 7.5.11.2. Financial performance
    • 7.5.11.3. Treatment Benchmarking
    • 7.5.11.4. Strategic initiatives
  • 7.5.12. Johnson & Johnson (MedTech)
    • 7.5.12.1. Company overview
    • 7.5.12.2. Financial performance
    • 7.5.12.3. Treatment Benchmarking
    • 7.5.12.4. Strategic initiatives
  • 7.5.13. phenox GmbH (Wallaby Medical)
    • 7.5.13.1. Company overview
    • 7.5.13.2. Financial performance
    • 7.5.13.3. Treatment Benchmarking
    • 7.5.13.4. Strategic initiatives
  • 7.5.14. Acandis GmbH
    • 7.5.14.1. Company overview
    • 7.5.14.2. Financial performance
    • 7.5.14.3. Treatment Benchmarking
    • 7.5.14.4. Strategic initiatives
  • 7.5.15. B. Braun SE
    • 7.5.15.1. Company overview
    • 7.5.15.2. Financial performance
    • 7.5.15.3. Treatment Benchmarking
    • 7.5.15.4. Strategic initiatives
  • 7.5.16. Integra LifeSciences
    • 7.5.16.1. Company overview
    • 7.5.16.2. Financial performance
    • 7.5.16.3. Treatment Benchmarking
    • 7.5.16.4. Strategic initiatives
  • 7.5.17. Infinity Neuro LLC
    • 7.5.17.1. Company overview
    • 7.5.17.2. Financial performance
    • 7.5.17.3. Treatment Benchmarking
    • 7.5.17.4. Strategic initiatives
  • 7.5.18. Penumbra, Inc.
    • 7.5.18.1. Company overview
    • 7.5.18.2. Financial performance
    • 7.5.18.3. Treatment Benchmarking
    • 7.5.18.4. Strategic initiatives
  • 7.5.19. Boston Scientific Corporation
    • 7.5.19.1. Company overview
    • 7.5.19.2. Financial performance
    • 7.5.19.3. Treatment Benchmarking
    • 7.5.19.4. Strategic initiatives
  • 7.5.20. Stryker
    • 7.5.20.1. Company overview
    • 7.5.20.2. Financial performance
    • 7.5.20.3. Treatment Benchmarking
    • 7.5.20.4. Strategic initiatives
  • 7.5.21. Peter LAZIC GmbH
    • 7.5.21.1. Company overview
    • 7.5.21.2. Financial performance
    • 7.5.21.3. Treatment Benchmarking
    • 7.5.21.4. Strategic initiatives
  • 7.5.22. Vesalio Inc.
    • 7.5.22.1. Company overview
    • 7.5.22.2. Financial performance
    • 7.5.22.3. Treatment Benchmarking
    • 7.5.22.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviation
• Table 2 North America hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
• Table 3 North America hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 4 North America hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 5 U.S. hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 6 U.S. hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 7 Canada hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 8 Canada hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 9 Mexico hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 10 Mexico hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 11 Europe hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
• Table 12 Europe hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 13 Europe hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 14 Germany hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 15 Germany hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 16 UK hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 17 UK hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 18 France hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 19 France hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 20 Italy hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 21 Italy hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 22 Spain hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 23 Spain hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 24 Denmark hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 25 Denmark hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 26 Sweden hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 27 Sweden hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 28 Norway hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 29 Norway hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 30 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
• Table 31 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 32 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 33 China hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 34 China hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 35 Japan hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 36 Japan hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 37 India hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 38 India hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 39 South Korea hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 40 South Korea hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 41 Australia hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 42 Australia hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 43 Thailand hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 44 Thailand hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 45 Latin America hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
• Table 46 Latin America hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 47 Latin America hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 48 Brazil hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 49 Brazil hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 50 Argentina hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 51 Argentina hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 52 MEA hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
• Table 53 MEA hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 54 MEA hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 55 South Africa hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 56 South Africa hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 57 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 58 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 59 UAE hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 60 UAE hemorrhagic & ischemic stroke treatment devices market, by application, 2021 - 2033 (USD Million)
• Table 61 UAE hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
• Table 62 Kuwait hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
• Table 63 Kuwait hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Hemorrhagic & ischemic stroke treatment devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Data analysis models
• Fig. 5 Market formulation and validation
• Fig. 6 Data validating & publishing
• Fig. 7 Market snapshot
• Fig. 8 Segment snapshot
• Fig. 9 Competitive landscape snapshot
• Fig. 10 Hemorrhagic & ischemic stroke treatment devices - market size and growth prospects (USD Million)
• Fig. 11 Hemorrhagic & ischemic stroke treatment devices market: Industry Value Chain Analysis
• Fig. 12 Hemorrhagic & ischemic stroke treatment devices market: Market Dynamics
• Fig. 13 Hemorrhagic & ischemic stroke treatment devices market: PORTER's Analysis
• Fig. 14 Hemorrhagic & ischemic stroke treatment devices market: PESTEL Analysis
• Fig. 15 Hemorrhagic & ischemic stroke treatment devices market share by treatment, 2025 & 2033 (USD Million)
• Fig. 16 Hemorrhagic & ischemic stroke treatment devices market, by treatment: market share, 2023 & 2030
• Fig. 17 Aneurysm & hemorrhagic stroke interventions market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 18 By indication market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 19 Intracranial aneurysm market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 20 cSDH (MMA Embolization) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 21 AVM & AVF embolization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 22 By device market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 23 Embolization coiling systems market share by application, 2025 & 2033 (USD Million)
• Fig. 24 Bare platinum coils market share by application, 2025 & 2033 (USD Million)
• Fig. 25 Coated / bioactive coils market share by application, 2025 & 2033 (USD Million)
• Fig. 26 Flow diversion systems market share by application, 2025 & 2033 (USD Million)
• Fig. 27 Standard flow-diverting stents (eg, pipeline) market share by application, 2025 & 2033 (USD Million)
• Fig. 28 Next-generation / surface-modified flow diverters market share by application, 2025 & 2033 (USD Million)
• Fig. 29 Intrasaccular flow disruption devices market share by application, 2025 & 2033 (USD Million)
• Fig. 30 Woven endobridge (WEB) market share by application, 2025 & 2033 (USD Million)
• Fig. 31 Luna aneurysm embolization system market share by application, 2025 & 2033 (USD Million)
• Fig. 32 Liquid embolization agents market share by application, 2025 & 2033 (USD Million)
• Fig. 33 Non-adhesive liquid embolics (onyx, squid, PHIL) market share by application, 2025 & 2033 (USD Million)
• Fig. 34 Adhesive liquid embolics (NBCA) market share by application, 2025 & 2033 (USD Million)
• Fig. 35 Ischemic stroke interventions (mechanical revascularization) market share by application, 2025 & 2033 (USD Million)
• Fig. 36 Stent retriever systems market share by application, 2025 & 2033 (USD Million)
• Fig. 37 Aspiration-based thrombectomy system market share by application, 2025 & 2033 (USD Million)
• Fig. 38 Cerebral angioplasty & vascular remodeling market share by application, 2025 & 2033 (USD Million)
• Fig. 39 Balloon angioplasty systems market share by application, 2025 & 2033 (USD Million)
• Fig. 40 Intracranial & carotid stenting systems market share by application, 2025 & 2033 (USD Million)
• Fig. 41 Coil-assisted adjunctive devices (balloon-assisted and stent-assisted) market share by application, 2025 & 2033 (USD Million)
• Fig. 42 Ancillary & procedural access devices market share by application, 2025 & 2033 (USD Million)
• Fig. 43 Guiding & distal access catheters market share by application, 2025 & 2033 (USD Million)
• Fig. 44 Microcatheters market share by application, 2025 & 2033 (USD Million)
• Fig. 45 Access sheaths & wires market share by application, 2025 & 2033 (USD Million)
• Fig. 46 Hemorrhagic & ischemic stroke treatment devices market share by end use, 2025 & 2033 (USD Million)
• Fig. 47 Hemorrhagic & ischemic stroke treatment devices market, by end use: market share, 2023 & 2030
• Fig. 48 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 49 Specialty neurosurgery centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 50 Ambulatory surgical centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
• Fig. 51 Regional marketplace: key takeaways
• Fig. 52 North America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 53 US hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 54 Canada hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 55 Mexico hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 56 Europe hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 57 UK hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 58 Germany hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 59 France hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 60 Italy hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 61 Spain hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 62 Sweden hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 63 Denmark hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 64 Norway hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 65 Asia Pacific hemorrhagic & ischemic stroke treatment devices market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 66 China hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 67 Japan hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 68 India hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 69 South Korea hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 70 Australia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 71 Thailand hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 72 Latin America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 73 Brazil hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 74 Argentina hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 75 MEA hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 76 South Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 77 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 78 UAE hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 79 Kuwait hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 80 Key company categorization
• Fig. 81 Company market positioning
• Fig. 82 Key company market share analysis, 2025
• Fig. 83 Strategic framework